Drug repositioning based on weighted local information augmented graph neural network
© The Author(s) 2023. Published by Oxford University Press..
Drug repositioning, the strategy of redirecting existing drugs to new therapeutic purposes, is pivotal in accelerating drug discovery. While many studies have engaged in modeling complex drug-disease associations, they often overlook the relevance between different node embeddings. Consequently, we propose a novel weighted local information augmented graph neural network model, termed DRAGNN, for drug repositioning. Specifically, DRAGNN firstly incorporates a graph attention mechanism to dynamically allocate attention coefficients to drug and disease heterogeneous nodes, enhancing the effectiveness of target node information collection. To prevent excessive embedding of information in a limited vector space, we omit self-node information aggregation, thereby emphasizing valuable heterogeneous and homogeneous information. Additionally, average pooling in neighbor information aggregation is introduced to enhance local information while maintaining simplicity. A multi-layer perceptron is then employed to generate the final association predictions. The model's effectiveness for drug repositioning is supported by a 10-times 10-fold cross-validation on three benchmark datasets. Further validation is provided through analysis of the predicted associations using multiple authoritative data sources, molecular docking experiments and drug-disease network analysis, laying a solid foundation for future drug discovery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Briefings in bioinformatics - 25(2023), 1 vom: 22. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Meng, Yajie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Drug–disease association |
|---|
| Anmerkungen: |
Date Completed 01.12.2023 Date Revised 22.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/bib/bbad431 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365108774 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365108774 | ||
| 003 | DE-627 | ||
| 005 | 20240122231945.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/bib/bbad431 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1267.xml |
| 035 | |a (DE-627)NLM365108774 | ||
| 035 | |a (NLM)38019732 | ||
| 035 | |a (PII)bbad431 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Meng, Yajie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug repositioning based on weighted local information augmented graph neural network |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2023 | ||
| 500 | |a Date Revised 22.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press. | ||
| 520 | |a Drug repositioning, the strategy of redirecting existing drugs to new therapeutic purposes, is pivotal in accelerating drug discovery. While many studies have engaged in modeling complex drug-disease associations, they often overlook the relevance between different node embeddings. Consequently, we propose a novel weighted local information augmented graph neural network model, termed DRAGNN, for drug repositioning. Specifically, DRAGNN firstly incorporates a graph attention mechanism to dynamically allocate attention coefficients to drug and disease heterogeneous nodes, enhancing the effectiveness of target node information collection. To prevent excessive embedding of information in a limited vector space, we omit self-node information aggregation, thereby emphasizing valuable heterogeneous and homogeneous information. Additionally, average pooling in neighbor information aggregation is introduced to enhance local information while maintaining simplicity. A multi-layer perceptron is then employed to generate the final association predictions. The model's effectiveness for drug repositioning is supported by a 10-times 10-fold cross-validation on three benchmark datasets. Further validation is provided through analysis of the predicted associations using multiple authoritative data sources, molecular docking experiments and drug-disease network analysis, laying a solid foundation for future drug discovery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a drug repositioning | |
| 650 | 4 | |a drug–disease association | |
| 650 | 4 | |a graph attention mechanism | |
| 650 | 4 | |a graph neural network | |
| 650 | 4 | |a local information augmentation | |
| 700 | 1 | |a Wang, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Junlin |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Changcheng |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Xianfang |e verfasserin |4 aut | |
| 700 | 1 | |a Peng, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Bengong |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Geng |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Jialiang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Briefings in bioinformatics |d 2000 |g 25(2023), 1 vom: 22. Nov. |w (DE-627)NLM11366883X |x 1477-4054 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2023 |g number:1 |g day:22 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/bib/bbad431 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2023 |e 1 |b 22 |c 11 | ||